Cantitate/Preț
Produs
Total produse
Vezi coșul
Antibiotic Policies: Fighting Resistance de Ian M. Gould

Antibiotic Policies: Fighting Resistance

Editat de Ian M. Gould, Jos W.M. van der Meer
en Limba Engleză Hardback – 11 sep 2007
This volume examines many of the crucial issues of resistance in a clinical context, with an emphasis on MRSA; surely the greatest challenge to our antibiotic and infection control policies that modern health care systems have ever seen. Other chapters explore the psychology of prescribing, modern management techniques as an adjunct to antibiotic policies, and the less obvious downsides of antibiotic use.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (3) 97337 lei  38-44 zile
  Springer – 7 dec 2014 97337 lei  38-44 zile
  Springer Us – 18 noi 2010 98104 lei  38-44 zile
  Springer Us – 29 oct 2010 142776 lei  43-57 zile
Hardback (3) 108910 lei  43-57 zile
  Springer – 25 sep 2011 108910 lei  43-57 zile
  Springer Us – 11 sep 2007 109434 lei  43-57 zile
  Springer Us – 17 sep 2004 143705 lei  43-57 zile

Preț: 109434 lei

Preț vechi: 115193 lei
-5% Nou

Puncte Express: 1642
Preț estimativ în valută:
20959€ • 21593$ • 17557£

Carte tipărită la comandă

Livrare economică 24 februarie-10 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780387708409
ISBN-10: 0387708405
Pagini: 285
Ilustrații: XIII, 285 p.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.62 kg
Ediția:2008
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States

Public țintă

Research

Descriere

In 1971, I started a fellowship in infectious diseases and medical microbiology at the Channing Laboratory of the Harvard Medical Service at Boston City Hospital. My mentor, Dr. Maxwell Finland, had encouraged me to return there from the Center for Disease Control (as CDC was known then), where I had studied inf- tious diseases epidemiology and hospital-associated infection epidemiology, with the idea that we would review the demographic patterns of bacteremia and several other infections during Dr. Finland’s long tenure at the hospital. We did so, but I was surprised to find that he also invited me to help with the assessment of the success or failure of the programs to control antimicrobial use that he and c- leagues had put into place at the hospital over several years. The paper describing that review finally was published in 1974, after a long and tortuous process of review at several journals. Several reviewers felt that such attempts to improve use amounted to interference with the patient’s physician to do what was best. Others felt that such programs focused incorrectly on a subject other than treating the current patient. Fortunately, today, it is clear that antimicrobial resistance results in major part, but not entirely, from the ways that we use antimicrobial agents, and that the ov- all interests of patients in general, as well as those of society, are well served by efforts to use these drugs as well as possible.

Cuprins

Consequences of Antimicrobial Chemotherapy: Overgrowth, Resistance, and Virulence.- The Process of Antibiotic Prescribing: Can It Be Changed?.- Cultural and Socioeconomic Determinants of Antibiotic Use.- Electronic Prescribing.- Prevalence Surveys of Antimicrobial Use in Hospitals: Purpose, Practicalities, and Pitfalls.- Antibiotic Use in Hospitals in the United States SCOPE-MMIT Antimicrobial Surveillance Network.- New Hospital Initiatives in Fighting Resistance.- Antimicrobial Resistance: Preventable or Inevitable?.- Fighting Antimicrobial Resistance in the Mediterranean Region.- Cystic Fibrosis—Coping with Resistance.- Community-Acquired Pneumonia—Back to Basics.- Hospital-Acquired Pneumonia: Diagnostic and Treatment Options.- Optimizing Antimicrobial Chemotherapy in the ICU—A Review.- Risk Assessment for Methicillin-Resistant Staphylococcus aureus.- What Do We Do with Methicillin-Resistant Staphylococcus aureus in Surgery?.- Control of Healthcare-Associated Methicillin-ResistantStaphylococcus aureus.

Textul de pe ultima copertă

Antibiotic resistance has reached epidemic proportions in most hospitals and many communities around the world. While control methods have traditionally (and usually unsuccessfully) relied on preventing cross infection it is increasingly obvious that new solutions are needed. There is growing evidence that the solution will lie in more careful use of antibiotics in the future. The golden age of antibiotic therapy has gone, probably for good and prescribers (and society at large) will have to accept that, in future, antibiotics will not be the "cure all" we have been accustomed to. This book addresses many of the key issues taxing our society and hospitals in an era of epidemic resistance and shortage of new antibiotics. Written by internationally renowned experts in the field, this volume will provide practical advice and inform control strategies for the most urgent of problems related to antibiotic resistance epidemic for years to come. Antibiotic Policies: Fighting Resistance is an ideal volume for health professionals with an interest in this field.

Caracteristici

Complete reference to antibiotics, encompassing all aspects of policy, theory, and resistance
Editors are well-known and highly respected in the international infectious diseases community